DARIOHEALTH CORP (DRIO) Stock Fundamental Analysis

NASDAQ:DRIO • US23725P3082

11.72 USD
+0.47 (+4.18%)
Last: Feb 13, 2026, 08:03 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to DRIO. DRIO was compared to 35 industry peers in the Health Care Technology industry. The financial health of DRIO is average, but there are quite some concerns on its profitability. DRIO is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • In the past year DRIO has reported negative net income.
  • In the past year DRIO has reported a negative cash flow from operations.
  • In the past 5 years DRIO always reported negative net income.
  • DRIO had a negative operating cash flow in each of the past 5 years.
DRIO Yearly Net Income VS EBIT VS OCF VS FCFDRIO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20M -40M -60M

1.2 Ratios

  • The Return On Assets of DRIO (-31.52%) is worse than 62.86% of its industry peers.
  • The Return On Equity of DRIO (-49.53%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -31.52%
ROE -49.53%
ROIC N/A
ROA(3y)-51.31%
ROA(5y)-65.11%
ROE(3y)-81.98%
ROE(5y)-91.09%
ROIC(3y)N/A
ROIC(5y)N/A
DRIO Yearly ROA, ROE, ROICDRIO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800

1.3 Margins

  • DRIO's Gross Margin of 56.86% is in line compared to the rest of the industry. DRIO outperforms 45.71% of its industry peers.
  • DRIO's Gross Margin has improved in the last couple of years.
  • DRIO does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 56.86%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y36.46%
GM growth 5Y7.37%
DRIO Yearly Profit, Operating, Gross MarginsDRIO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300 -400

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. Health

2.1 Basic Checks

  • DRIO does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, DRIO has more shares outstanding
  • DRIO has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for DRIO has been reduced compared to a year ago.
DRIO Yearly Shares OutstandingDRIO Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M
DRIO Yearly Total Debt VS Total AssetsDRIO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

  • Based on the Altman-Z score of -4.71, we must say that DRIO is in the distress zone and has some risk of bankruptcy.
  • DRIO's Altman-Z score of -4.71 is on the low side compared to the rest of the industry. DRIO is outperformed by 77.14% of its industry peers.
  • A Debt/Equity ratio of 0.41 indicates that DRIO is not too dependend on debt financing.
  • DRIO has a Debt to Equity ratio of 0.41. This is in the lower half of the industry: DRIO underperforms 71.43% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.41
Debt/FCF N/A
Altman-Z -4.71
ROIC/WACCN/A
WACC10.84%
DRIO Yearly LT Debt VS Equity VS FCFDRIO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M 80M

2.3 Liquidity

  • A Current Ratio of 4.55 indicates that DRIO has no problem at all paying its short term obligations.
  • DRIO's Current ratio of 4.55 is amongst the best of the industry. DRIO outperforms 82.86% of its industry peers.
  • DRIO has a Quick Ratio of 4.02. This indicates that DRIO is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 4.02, DRIO belongs to the top of the industry, outperforming 82.86% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.55
Quick Ratio 4.02
DRIO Yearly Current Assets VS Current LiabilitesDRIO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 74.56% over the past year.
  • The Revenue has been growing slightly by 7.29% in the past year.
  • Measured over the past years, DRIO shows a very strong growth in Revenue. The Revenue has been growing by 29.03% on average per year.
EPS 1Y (TTM)74.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%159.2%
Revenue 1Y (TTM)7.29%
Revenue growth 3Y9.65%
Revenue growth 5Y29.03%
Sales Q2Q%-32.55%

3.2 Future

  • The Earnings Per Share is expected to grow by 15.89% on average over the next years. This is quite good.
  • DRIO is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.37% yearly.
EPS Next Y-118.81%
EPS Next 2Y28.29%
EPS Next 3Y6.29%
EPS Next 5Y15.89%
Revenue Next Year-10.78%
Revenue Next 2Y-2%
Revenue Next 3Y5.47%
Revenue Next 5Y9.37%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
DRIO Yearly Revenue VS EstimatesDRIO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 50M 100M 150M 200M 250M
DRIO Yearly EPS VS EstimatesDRIO Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 -200 -400 -600 -800

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • DRIO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year DRIO is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DRIO Price Earnings VS Forward Price EarningsDRIO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
DRIO Per share dataDRIO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y28.29%
EPS Next 3Y6.29%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for DRIO!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

DARIOHEALTH CORP

NASDAQ:DRIO (2/13/2026, 8:03:53 PM)

11.72

+0.47 (+4.18%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)11-13
Earnings (Next)03-09
Inst Owners11.75%
Inst Owner Change1.72%
Ins Owners12.01%
Ins Owner Change5.22%
Market Cap79.23M
Revenue(TTM)24.73M
Net Income(TTM)-37.11M
Analysts82
Price Target18.36 (56.66%)
Short Float %1.25%
Short Ratio2.98
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)91.8%
Min EPS beat(2)24.37%
Max EPS beat(2)159.22%
EPS beat(4)3
Avg EPS beat(4)59.87%
Min EPS beat(4)-17.64%
Max EPS beat(4)159.22%
EPS beat(8)7
Avg EPS beat(8)49.83%
EPS beat(12)9
Avg EPS beat(12)35%
EPS beat(16)11
Avg EPS beat(16)28.68%
Revenue beat(2)0
Avg Revenue beat(2)-18.56%
Min Revenue beat(2)-23.78%
Max Revenue beat(2)-13.34%
Revenue beat(4)1
Avg Revenue beat(4)-11.91%
Min Revenue beat(4)-23.78%
Max Revenue beat(4)0.92%
Revenue beat(8)1
Avg Revenue beat(8)-11.12%
Revenue beat(12)3
Avg Revenue beat(12)-10.13%
Revenue beat(16)5
Avg Revenue beat(16)-8.21%
PT rev (1m)-1.37%
PT rev (3m)-19.1%
EPS NQ rev (1m)9.85%
EPS NQ rev (3m)8.34%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)-1.47%
Revenue NQ rev (3m)-17.83%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.2
P/FCF N/A
P/OCF N/A
P/B 1.06
P/tB 71.89
EV/EBITDA N/A
EPS(TTM)-5.24
EYN/A
EPS(NY)-4.39
Fwd EYN/A
FCF(TTM)-3.98
FCFYN/A
OCF(TTM)-3.96
OCFYN/A
SpS3.66
BVpS11.08
TBVpS0.16
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -31.52%
ROE -49.53%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 56.86%
FCFM N/A
ROA(3y)-51.31%
ROA(5y)-65.11%
ROE(3y)-81.98%
ROE(5y)-91.09%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y36.46%
GM growth 5Y7.37%
F-Score5
Asset Turnover0.21
Health
Industry RankSector Rank
Debt/Equity 0.41
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 2.89%
Cap/Sales 0.55%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.55
Quick Ratio 4.02
Altman-Z -4.71
F-Score5
WACC10.84%
ROIC/WACCN/A
Cap/Depr(3y)8.55%
Cap/Depr(5y)19.33%
Cap/Sales(3y)1.81%
Cap/Sales(5y)1.66%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)74.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%159.2%
EPS Next Y-118.81%
EPS Next 2Y28.29%
EPS Next 3Y6.29%
EPS Next 5Y15.89%
Revenue 1Y (TTM)7.29%
Revenue growth 3Y9.65%
Revenue growth 5Y29.03%
Sales Q2Q%-32.55%
Revenue Next Year-10.78%
Revenue Next 2Y-2%
Revenue Next 3Y5.47%
Revenue Next 5Y9.37%
EBIT growth 1Y33.15%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year62.79%
EBIT Next 3Y25.02%
EBIT Next 5Y16.13%
FCF growth 1Y14.67%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y13.57%
OCF growth 3YN/A
OCF growth 5YN/A

DARIOHEALTH CORP / DRIO FAQ

What is the fundamental rating for DRIO stock?

ChartMill assigns a fundamental rating of 3 / 10 to DRIO.


Can you provide the valuation status for DARIOHEALTH CORP?

ChartMill assigns a valuation rating of 0 / 10 to DARIOHEALTH CORP (DRIO). This can be considered as Overvalued.


Can you provide the profitability details for DARIOHEALTH CORP?

DARIOHEALTH CORP (DRIO) has a profitability rating of 1 / 10.


How financially healthy is DARIOHEALTH CORP?

The financial health rating of DARIOHEALTH CORP (DRIO) is 4 / 10.